• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

tetano

Editor, Senior Moderator
J Infect. 2015 Dec 15. pii: S0163-4453(15)00372-2. doi: 10.1016/j.jinf.2015.11.007. [Epub ahead of print]
[h=1]Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis.[/h] Rodr?guez AH[SUP]1[/SUP], Avil?s-Jurado FX[SUP]2[/SUP], D?az E[SUP]3[/SUP], Schuetz P[SUP]4[/SUP], Trefler BCs SI[SUP]5[/SUP], Sol?-Viol?n J[SUP]6[/SUP], Cordero L[SUP]7[/SUP], Vidaur L[SUP]8[/SUP], Estella ?[SUP]9[/SUP], Pozo Laderas JC[SUP]10[/SUP], Socias L[SUP]11[/SUP], Vergara JC[SUP]12[/SUP], Zaragoza R[SUP]13[/SUP], Bonastre J[SUP]14[/SUP], Guerrero JE[SUP]15[/SUP], Suberviola B[SUP]16[/SUP], C C[SUP]17[/SUP], Restrepo MI[SUP]18[/SUP], Mart?n-Loeches I[SUP]19[/SUP]; SEMICYUC/GETGAG working group.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] To define which variables upon ICU admission could be related to the presence of coinfection using CHAID (Chi-squared Automatic Interaction Detection) analysis.
[h=4]METHODS:[/h] A secondary analysis from a prospective, multicentre, observational study (2009-2014) in ICU patients with confirmed A(H1N1)pdm09 infection. We assessed the potential of biomarkers and clinical variables upon admission to the ICU for coinfection diagnosis using CHAID analysis. Performance of cut-off points obtained was determined on the basis of the binominal distributions of the true (+) and true(-) results.
[h=4]RESULTS:[/h] Of the 972 patients included, 196 (20.3%) had coinfection. Procalcitonin (PCT;ng/mL 2.4 vs. 0.5, p<0.001), but not C-reactive protein (CRP;mg/dL 25 vs. 38.5; p=0.62) was higher in patients with coinfection. In CHAID analyses, PCT was the most important variable for coinfection. PCT<0.29ng/mL showed high sensitivity (Se=88.2%), low Sp(33.2%) and high negative predictive value (NPV= 91.9%). The absence of shock improved classification capacity. Thus, for PCT <0.29ng/mL, the Se was 84%, the Sp 43% and an NPV of 94% with a post-test probability of coinfection of only 6%.
[h=4]CONCLUSION:[/h] PCT has a high negative predictive value (94%) and lower PCT levels seems to be a good tool for excluding coinfection, particularly for patients without shock.
Copyright ? 2015. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] CHAID analysis; Community-acquired pneumonia; Influenza A(H1N1)pmd; Procalcitonin; Prognosis; Respiratory Coinfection; septic shock

PMID: 26702737 [PubMed - as supplied by publisher]
 
Back
Top Bottom